![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/30 | (2006.01) |
A61K 39/395 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
C12N 5/12 | (2006.01) | ||
A61K 51/10 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
C07K 16/18 | (2006.01) | ||
C07K 16/28 | (2006.01) | ||
A61K 39/00 | (2006.01) |
(11) | Number of the document | 2325210 |
(13) | Kind of document | T |
(96) | European patent application number | 10011772.0 |
Date of filing the European patent application | 2006-11-24 | |
(97) | Date of publication of the European application | 2011-05-25 |
(45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
(46) | Date of publication of the claims translation | 2018-11-12 |
(30) | Number | Date | Country code |
05025657 | 2005-11-24 | EP |
(72) |
Sahin, Ugur, DE
Türeci, Özlem, DE
Usener, Dirk, DE
Fritz, Stefan, DE
Uherek, Christoph, DE
Brandenburg, Gunda, DE
Geppert, Harald-Gerhard, DE
Schröder, Anja Kristina, DE
Thiel, Philippe, DE
|
(73) |
Astellas Pharma Inc.,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411,
JP
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb, Freiligrathstrasse 12, 55131 Mainz, DE |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Monokloniniai antikūnai prieš klaudiną 18, skirti vėžio gydymui |
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER |
Payment date | Validity (years) | Amount | |
2024-10-31 | 19 | 347.00 EUR |
2025-11-24 |